Understanding intestinal absorption for pharmaceutical compounds is vital to estimate bioavailability and therefore the in vivo potential of a drug. This study considers the application of micellar liquid chromatography (MLC) to predict passive intestinal absorption with a selection of model compounds. MLC is already known to aid prediction of absorption using simple surfactant systems however, with this study the focus was on the presence of a more complex, bile salt surfactant, as would be encountered in the in vivo environment. As a result, MLC using a specific bile salt has been confirmed as an ideal in vitro system to predict the intestinal permeability for a wide range of drugs, through the development of a quantitative partition-absorption relationship. MLC offers many benefits including environmental, economic, time-saving and ethical advantages compared with the traditional techniques employed to obtain passive intestinal absorption values.
Introduction
The most favourable option for drug administration is the oral route, accounting for the majority of pharmaceutical formulations on the market. A large percentage of these products are absorbed within the gastrointestinal (GI) tract thus it is essential to quantify the extent of absorption to predict bioavailability. Most new chemical entities (NCEs) intended for oral administration are within Class II or IV of the Biopharmaceutics Classification System (BCS), i.e. of low aqueous solubility (Williams, Trevaskis, Charman, Shanker, Charman, Pouton and Porter 2013). As a result these compounds tend to exhibit poor bioavailability which can be problematic for development. Facilitating the prediction of drug absorption is therefore fundamental to maximise potential bioavailability, and consequently, efficacy of an NCE.
Traditionally, in vivo performance following oral administration has been predicted using animal models. In recent years this has been less favourable for reasons including interspecies variability (Martignoni, Groothuis and de Kanter 2006) , substantial economic costs and ethical considerations (Zurlo and Hutchinson 2014) . For these reasons research has focused on the development of alternatives to such models. One of the most widely researched in vitro methods to simulate in vivo performance is the application of dissolution studies in biorelevant media (Berthelsen, Sjögren, Jacobsen, Kristensen, Holm, Abrahamsson and Müllertz 2014) . It is believed that the use of physiologically relevant media is crucial as the components present, for example bile salts, are present in intestinal fluids allowing a closer replication of the in vivo scenario (Tomaszewska, Karki, Shur, Price and Fotaki 2013).
The composition of GI fluids is well characterised with respect to pH, buffer capacity, osmolarity, surface tension and lipid concentration under fasted and fed conditions. Numerous studies have confirmed the relationship between the impact of these properties through preformulation studies, allowing an estimation of the fraction of drug absorbed in vivo for orally administered compounds (Bergström, Holm, Jørgensen, Andersson, Artursson, Beato, Borde, Box, Brewster, Dressman, Feng, Halbert, Kostewicz, McAllister, Muenster, Thinnes, Taylor and Mullertz 2014) . However, some researchers have found that dissolution testing by itself may not be adequate and it may be more beneficial to undertake the simultaneous assessment of dissolution and permeation (Sugano, Kataoka, da Costa Mathews and Yamashita 2010).
Another technique to predict in vivo permeability is the parallel artificial membrane permeability assay, also known as PAMPA. This assay has been used previously to predict permeability through a range of biological environments including skin (Ottaviani, Martel and Carrupt 2006) , the blood brain barrier (Di, Kerns, Fan, McConnell and Carter 2003) and the GI tract (Bujard, Sol, Carrupt and Martel 2014) . Although it has been shown to be useful for in vivo prediction, PAMPA does have some limitations, for example unpredictable drug retention for highly lipophilic drugs (Bendels, Tsinman, Wagner, Lipp, Parrilla, Kansy and Avdeef 2006) and a significant unstirred water layer (Avdeef, Nielsen and Tsinman 2004, Ruell, Tsinman and Avdeef 2003) . Some of these challenges have been investigated in an attempt to overcome these difficulties to improve accuracy and precision with a degree of success in certain aspects (Buckley, Fischer, Fricker and Brandl 2012) .
Many researchers consider the 'gold standard' for predicting intestinal absorption to be the Caco-2 model (Wuyts, Riethorst, Brouwers, Tack, Annaert and Augustijns 2015) . This is a cell culture model consisting of monolayers cultivated on permeable growth inserts. Such models exhibit structural and biological properties similar to those in vivo with the expression of appropriate enzymes, conferring their suitability as a model system. However, cellular models are renowned for their limited reproducibility, extensive culturing requirements and economic cost (Buckley, Fischer, Fricker and Brandl 2012) . Some research has attempted to enhance the biorelevance of permeability data, for example by using fasted state human intestinal fluid as the solvent system with prediction for a series of 16 model drugs (Wuyts, Riethorst, Brouwers, Tack, Annaert and Augustijns 2015) .
Other less well known models have also been proposed, some of which are modifications of those previously discussed and others more novel. One such example of the latter is the application of spectrofluorimetry and derivative spectrophotometry to determine partition coefficients to assess the role of mixed (bile salt) micelles in gastrointestinal absorption (De Castro, Gameiro, Guimarães, Lima and Reis 2001) . Interestingly, it was found that hydrophobic compounds are fully incorporated within mixed bile salt micelles whereas amphiphilic drugs are not. This work demonstrates the significant effect the presence of bile salt micelles can have on absorption, and therefore, bioavailability. Ideally, the chosen surfactant will have a comparatively low critical micellar concentration (CMC) and aggregation number. Upon injection of the sample (solute), several competing phenomena occur. Each compound within the sample will partition between the bulk aqueous phase and micellar aggregates plus the bulk aqueous phase and surfactant-coated stationary phase. These interactions will dictate the retention time of the solute which can then be measured using a variety of analytical techniques, such as UV or fluorescence spectroscopy. However, the application of MLC with micellar systems that are actually encountered within the GI tract, i.e. bile salt micelles, has not been investigated prior to this study.
Through combining the advantages of MLC with the incorporation of micelles that are known to exist in vivo will aid the development of an in vitro model that is simple, reproducible, inexpensive, accurate and moreover, precise, for the prediction of human absorption data.
In summary, the main aim of this study was to investigate the use of MLC with bile salt to develop a quantitative partition-absorption relationship, thus creating an alternative in vitro system to predict intestinal permeability for pharmaceutical compounds.
Micellar Liquid Chromatography Method and Instrumentation
A detailed description of the basic MLC methodology employed in this study has been published previously (Waters, Shahzad and Stephenson 2013) . In summary, each mobile phase containing the bile salt surfactant was pumped through the chromatographic system (Severn Analytical SA 6410B) with a reversed phase cyanopropyl column (Spherisorb 5μm, 15cm x 4.6 mm i.d.) and a flow rate of 1.34 mL per minute. The selection of this column and flow rate was decided based on previous work that proves the superiority of using a cyanopropyl column over C 18 due to its tendency to adsorb less surfactant and the binding of the surfactant to the bonded phase through electrostatic interaction decreasing the charged layer on the surface of the column (Waters, Shahzad and Stephenson 2013). Drug samples (0.2 mM) in a solvent identical to that of the mobile phase were injected via a Rheodyne injector. A UV detector (Waters 2487), set at a wavelength appropriate for each drug (221 -360 nm), identified retention of the solute within the column as a function of time. Data were recorded and then analysed to obtain retention factors and each run was repeated a minimum of three times to ensure reasonable accuracy and precision were achieved. A high level of reproducibility was attained for the retention data with a maximum standard deviation of 0.975 for all assays.
Materials and Reagents
An aqueous solution containing a bile salt surfactant, namely sodium deoxycholate (NaDC, Figure 1 
Data Analysis
In agreement with previous work, it was possible to calculate a value for the micelle/water partition coefficient (logP mw ) by plotting the surfactant concentration (after subtraction of the CMC, i.e. 5 mM) with the inverse of the capacity factor. A representative chromatogram can be seen in Figure 2 . It should be noted that pH and ionic strength were not maintained at a constant value during this work as it was thought the addition of further compounds to the mobile phase may interfere with the partitioning process. 
Results and discussion

Determination of log P mw
Sodium deoxycholate (NaDC) is a well-known bile salt surfactant present in intestinal fluids in the GI tract. Moreover, NaDC forms micellar structures that aid the passive absorption of compounds in vivo ( olm, Mul lert and Mu 2013). The ability of NaDC-based MLC to predict human oral drug absorption was evaluated using a set of 14 drugs of variable structure and physicochemical properties. All of the compounds analysed were known to undergo passive absorption with reliable in vivo data available. Retention data for each compound led to the calculation of micelle-water partition coefficient (P mw ) values which were then analysed alongside oral absorption data from published literature data. A summary of the calculated P mw values and percentages of oral absorption (from previously published data) can be found in Table 1 . Also the determination coefficients (R 2 ) for the linear equations relating the inverse of the capacity factor for all drugs against the micellar concentrations of NaDC used are stated in Table 2 . 
Prediction of HIA values
As a result, all drugs with percentages of absorption of 100 % or 0 % were excluded from the training set for simplification.
A series of molecular descriptors (polar surface area, freely rotating bonds, number of hydrogen bond donors/acceptors, molecular weight, molar volume and solubility) permitted the development of an appropriate equation using multiple regression analysis. Descriptors present in the final model were assessed for significance and relative importance using standardised coefficients and associated P-values where the standardised coefficients for log P mw (micelle/water partition coefficient), Mwt (molecular weight) and Sw (solubility in water) were found to be -0.431, 1.050 and 0.761 respectively while their P values at 95 % confidence level were found to be 0.007, 0.000 and 0.001 respectively which proves their statistical significance. Through combining the data in Table 1 and Table 2 Overall, the optimal model obtained incorporated 3 descriptors and is as follows Where logP mw is the partition coefficient experimentally determined by MLC, Mwt is the molecular weight and Sw is the solubility in water ( Table 2 ). The value obtained using All covariates were statistically significant (t 1 =-3.42, p<0.05 for log P mw ; t 1 =-6.93, p<0.05 for molecular weight; t 1 =4.84, p<0.05 for aqueous solubility), with the model F-ratio also being statistically significant (F=20.99, p<0.05). None of the drugs used in the current dataset used in development of the previous model were found to have high residuals or to be influential according to studentised residuals or Cook's distance. Also the consistency of the R 2 adj and R 2 Pred. does not suggest any evidence of model or data inadequacies in the current model. In summary, the values presented in Table 1 for HIA % predicted versus those from literature show a remarkably similar trend. For example, differences between the two values are 0 % (theophylline) through to a maximum of only 7.6 % (acetylsalicylic acid) with the vast majority successfully predicting within 4 % of the literature value. 
Comparison with other methods to predict HIA
Predicting the extent to which drugs may permeate the intestinal barrier is a key factor in predicting subsequent bioavailability. As previously discussed, there are several methods to predict intestinal absorption with data publicly available which allows comparisons to be made between this MLC-based method and others. Firstly, compared with Caco-2 absorption data, it can be said that the MLC method is comparable in predictive ability yet simpler, faster and cheaper to undertake. A variety of values have been published for Caco-2 absorption, such as the work of Stepnik et al. (Stȩpnik, Malinowska and Rój 2014) , with published data ranging in predictive ability where, in general, the level of prediction is similar to that published in this work. Based on the comparable ability of MLC for prediction along with the variety of advantages it appears to confirm its potential as a method of choice.
Secondly, artificial membrane based techniques, such as PAMPA, have been applied to the prediction of intestinal absorption. As with published data for Caco-2 absorption models, predictions have been made using PAMPA and their success rate have been generally high, for example the work of (Bujard, Sol, Carrupt and Martel 2014) . Again, the predictive ability of the MLC method presented in this paper is generally comparable with that using artificial membranes yet does not pose the same limitations as discussed earlier.
Thirdly, MLC has been considered prior to this work in a limited manner with the use of simpler surfactant systems, such as SDS and Brij 35. In this case there are no advantages related to the method employed as both require a similar set-up and therefore time and economic requirements. However, the benefits of using a bile salt surfactant are clearly evident based on the increased similarity to the in vivo scenario which is reflected in the enhanced predictive ability. For example, compared with the work of Molero-Monfort et al. (Molero-Monfort, Escuder-Gilabert, Villanueva-Camañas, Sagrado and Medina-Hernández 2001) and Stepnik et al. (Stȩpnik, Malinowska and Rój 2014) , the data presented in this research displays a closer fit with human intestinal absorption data. Also other work has been undertaken using sodium cholate and sodium taurodeoxycholate which were also used in prediction of intestinal absorption and the obtained models support the closer fit of the data in this paper to human intestinal absorption. These comparisons highlight the importance of surfactant choice when designing MLC experiments as it is very clear that the composition of the mobile phase can significantly affect drug retention which will ultimately affect absorption prediction.
Conclusions
Determining a good prediction of intestinal absorption chromatographically is an exciting advance in analysis for many reasons, not only for the replacement of using animal models but also to save time and money which will consequently help enhance the development of new drugs. Based on analysis for these model compounds it has been found that NaDC is suited to intestinal absorption prediction and appears to provide superior prediction compared with alternative methods. Furthermore, data presented in this study could be expanded to display the more general predictive ability of MLC for a wider set of compounds thus confirming its potential as a general method for predicting human intestinal absorption. 
